Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer Inc       

PFIZER INC
Mes dernières consult.
Most popular
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Pfizer Inc. : Pfizer Will Remove Claims on Breast and Colon Health From Centrum Label -Reuters

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/05/2012 | 11:26pm CEST

Pfizer Inc. (>> Pfizer Inc.) said it will remove claims that its Centrum multivitamin supplements promote breast and colon health from labels over the next six months, following a complaint by a watchdog group, Reuters reported Thursday.

The company will also revise websites and advertising for Centrum, the report said.

The report said the Center for Science in the Public Interest sent a letter to Pfizer Chief Executive Ian Read in April outlining its complaints and threatening a lawsuit if the claims weren't removed.

In a statement, Pfizer said it "disagrees with CSPI's concerns, but has agreed to make these changes in order to fully resolve the issues raised by the organization," Reuters reported.

Full story at http://www.reuters.com/article/2012/07/05/pfizer-centrum-idUSL2E8I5BR820120705

Write to [email protected]

Stocks mentioned in the article : Pfizer Inc.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PFIZER INC
10/16 PFIZER : Health and Human Services Department (HHS); Food and Drug Administratio..
10/16DJDaimler Reshapes Company to Meet Challenges of Changing Industry -- Update
10/16 PFIZER : Presents Full Results from Phase 2 Study of Next-Generation Investigati..
10/16 PFIZER INC. : - U.S. FDA Approves LYRICA CR Extended Release Tablets CV
10/16 Stocks mostly up
10/15 FG : Ignorance Responsible for High Cancer Mortality Rate
10/14 PFIZER : Union for International Cancer Control, Pfizer Award New Round of Grant..
10/14 PFIZER : PFE) Shareholder Nordea Investment Management Ab Has Boosted Position
10/14 PFIZER : FG - Ignorance Responsible for High Cancer Mortality Rate
10/13 PFIZER : and Glaxo may find romance over the counter with consumer goods deal
More news
News from SeekingAlpha
2015 Tracking Prem Watsa's Fairfax Financial Holdings Portfolio - Q2 2015 Update
2015 Antibiotics Stocks To Benefit From 21st Century Cures Act
2015 ISIS PHARMA STOCK DROPS ON GOOD NEWS : Re-Evaluating The Bull Case
2015 DOW DOGS : 14.63% More Returns From 5 Lowest Priced As Of August 6 Per indexArb
2015 Pfizer's GL-2045 an Orphan Drug for CIDP
Financials ($)
Sales 2017 52 676 M
EBIT 2017 19 837 M
Net income 2017 12 051 M
Debt 2017 24 101 M
Yield 2017 3,56%
P/E ratio 2017 19,34
P/E ratio 2018 17,00
EV / Sales 2017 4,53x
EV / Sales 2018 4,33x
Capitalization 214 B
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 38,2 $
Spread / Average Target 6,2%
EPS Revisions
Managers
NameTitle
Ian C. Read Chairman & Chief Executive Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Freda C. Lewis-Hall Chief Medical Officer & Executive Vice President
W. Don Cornwell Independent Director
Dennis Arthur Ausiello Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER INC216 409
JOHNSON & JOHNSON18.42%366 178
NOVARTIS13.23%225 160
ROCHE HOLDING LTD.5.20%216 764
PFIZER11.88%216 409
MERCK AND COMPANY7.68%172 887